Drugs Made in America Acquisition Ii CORP 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Drugs Made In America Acquisition II Corp. (DMIIU) has filed its annual report for the fiscal year ended December 31, 2025, detailing its activities as a blank check company and outlining its strategy for a future business combination.